The Abramson Lab

Calendar | Directory | Contact
subglobal1 link | subglobal1 link | subglobal1 link | subglobal1 link | subglobal1 link | subglobal1 link | subglobal1 link
subglobal2 link | subglobal2 link | subglobal2 link | subglobal2 link | subglobal2 link | subglobal2 link | subglobal2 link
subglobal3 link | subglobal3 link | subglobal3 link | subglobal3 link | subglobal3 link | subglobal3 link | subglobal3 link
subglobal4 link | subglobal4 link | subglobal4 link | subglobal4 link | subglobal4 link | subglobal4 link | subglobal4 link
subglobal5 link | subglobal5 link | subglobal5 link | subglobal5 link | subglobal5 link | subglobal5 link | subglobal5 link
subglobal6 link | subglobal6 link | subglobal6 link | subglobal6 link | subglobal6 link | subglobal6 link | subglobal6 link
subglobal7 link | subglobal7 link | subglobal7 link | subglobal7 link | subglobal7 link | subglobal7 link | subglobal7 link
subglobal8 link | subglobal8 link | subglobal8 link | subglobal8 link | subglobal8 link | subglobal8 link | subglobal8 link

Abramson Lab

Logos for NYU School of Medicine, Department of Medicine, and Division of Rheumatology

Clinical Arthritis Research

Collaborative, interdisciplinary biomarker studies are underway in the Division of Rheumatology, including a NIH-funded knee OA biomarker study, investigating novel clusters of genes expressed by peripheral blood leukocytes that can identify patients at risk for radiographic progression. 

This longitudinal study includes collaboration with the Department of Radiology to perform sequential 3.0 T MRI scans, and has already identified a cluster of genes associated with cytokine activation that predict knee OA susceptibility. 

In addition, OA program has also generated additional research contracts to investigate the role of SNPs of candidate cytokine genes on cytokine gene expression and OA susceptibility and phenotype.

About Us | Site Map | Privacy Policy | Contact Us | ©2007 NYU School of Medicine